Investor Overview
1968
2
2
Dexcel Pharma is an international specialty pharmaceutical company which focuses on the development, manufacturing and marketing of innovative prescription, generics and OTC pharmaceutical products.Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, we develop, manufacture and market value-added branded and genericpharmaceuticals. With a diverse product portfolio that spans more than 85 branded and generic products in over 175 dosage forms, our products are sold in the US, the UK and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.* Please note that Dexcel will keep your resume and application on file in case other positions will be relevant in the future
Portfolio (2)
Funding Rounds (2)
| Round | Date | Investors | |
|---|---|---|---|
 | ㅤBrainQ raises $40 million series B | August 2021 | 8 |
 | ㅤImmunai raises $60 million series A | February 2021 | 6 |
Funds (0)
Co-Investors (12)
| Investor Name | Investor Type | Founded | Portfolio | |
|---|---|---|---|---|
 | ㅤOurCrowd | Crowdfunding | 2013 | 75 |
 | ㅤViola Ventures | Venture Capital | 2000 | 50 |
 | ㅤTLV Partners | Venture Capital | 2015 | 34 |
 | ㅤHanaco Ventures | Venture Capital | 2017 | 27 |
 | ㅤMillhouse LLC | Family Office | 2001 | 6 |
